user

BIMEKIZUMAB EFFICACY IN MODERATE TO SEVERE PLAQUE PSORIASIS: IMPROVEMENTS IN FATIGUE OBSERVED IN TWO PHASE 3 STUDIES

被引：0
|
作者：
Gottlieb, Alice B. [1 ]
Augustin, Matthias [2 ]
Lambert, Jo [3 ]
Pinter, Andreas [4 ]
Savage, Laura J. [5 ]
Tsai, Tsen-Fang [6 ,7 ]
Foley, Peter [8 ]
Paul, Carle [9 ,10 ]
Warham, Rhys [11 ,12 ]
Lambert, Jeremy [1 ,13 ]
Wiegratz, Susanne [1 ,14 ]
Stahle, Mona [1 ,15 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY USA
[2] Univ Med Ctr Hamburg Eppendorf UKE, Inst Hlth Serv Res Dermatol & Nursing IVDP, Hamburg, Germany
[3] Ghent Univ Hosp, Ghent, Belgium
[4] Univ Hosp Frankfurt, Frankfurt, Germany
[5] Leeds Teaching Hosp NHS Trust, Leeds, England
[6] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan
[7] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
[8] Univ Melbourne, St Vincents Hosp Melbourne, Skin Hlth Inst, Carlton, Australia
[9] Toulouse Univ, Toulouse, France
[10] CHU, Toulouse, France
[11] Veramed, London, England
[12] UCB Pharm, Slough, England
[13] UCB Pharm, Colombes, France
[14] UCB Pharm, Monheim, Germany
[15] Karolinska Inst, Dept Med, Solna, Sweden
来源：
ACTA DERMATO-VENEREOLOGICA | 2024年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P-133
引用
收藏
页数：102
相关论文
共 50 条
  • [1] Bimekizumab efficacy in patients with moderate to severe plaque psoriasis during the randomized withdrawal and retreatment phase of BE READY, a phase 3 trial
    Blauvelt, Andrew
    Wu, Jashin J.
    Reich, Kristian
    Gooderham, Melinda
    Lebwohl, Mark
    White, Katy
    Cross, Nancy
    Cioffi, Christopher
    Papp, Kim A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB139 - AB139
  • [2] Bimekizumab efficacy in patients with moderate to severe plaque psoriasis receiving continuous bimekizumab or switching from adalimumab: Results from the phase 3 BE SURE trial
    Strober, Bruce E.
    Pinter, Andreas
    Warren, Richard B.
    Blauvelt, Andrew
    Sebastian, Michael
    De Cuyper, Dirk
    Vanvoorden, Veerle
    Wang, Maggie
    Madden, Cynthia
    Gooderham, Melinda
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB138 - AB138
  • [3] Efficacy of tofacitinib for the treatment of nail psoriasis: two 52-week phase 3 studies in patients with moderate to severe plaque psoriasis
    Merola, Joseph
    Tatulych, Svitlana
    Kaur, Mandeep
    Lan, Shuping
    Mallbris, Lotus
    Mamolo, Carla
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S9 - S9
  • [4] Efficacy of tofacitinib for the treatment of nail psoriasis: two 52-week Phase 3 studies in patients with moderate to severe plaque psoriasis
    Kaur, M.
    Merola, J.
    Tatulych, S.
    Mamolo, C.
    Lan, S.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 81 - 81
  • [5] Efficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week phase 3 studies in patients with moderate to severe plaque psoriasis
    Merola, Joseph
    Tatulych, Svitlana
    Mamolo, Carla
    Lan, Shuping
    Mallbris, Lotus
    Kaur, Mandeep
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB248 - AB248
  • [6] COMPARATIVE EFFICACY OF BIMEKIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS: A NETWORK META-ANALYSIS
    Armstrong, A.
    Reich, K.
    Warren, R. B.
    Taieb, V
    Fahrbach, K.
    Kazmierska, P.
    Betts, M.
    Neupane, B.
    Kiri, S.
    Gordon, K.
    [J]. VALUE IN HEALTH, 2021, 24 : S14 - S14
  • [7] Bimekizumab efficacy in subgroups defined by prior systemic treatment in patients with moderate to severe plaque psoriasis
    Rosmarin, David
    Lebwohl, Mark
    Feldman, Steven R.
    Staubach-Renz, Petra
    Davis, Leah
    Wixted, Krista
    Madden, Cynthia
    Gomez, Natalie Nunez
    Pinter, Andreas
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB146 - AB146
  • [8] Relationships between tildrakizumab dose, exposure, efficacy and safety in phase 3 studies in moderate to severe plaque psoriasis
    Strober, Bruce E.
    Sofen, Howard
    Yamauchi, Paul S.
    Mendelsohn, Alan M.
    Parno, Jeff
    Lowry, Simon
    Rozzo, Stephen J.
    Elewski, Boni E.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB117 - AB117
  • [9] Two phase 3 studies of oral tofacitinib in patients with moderate to severe plaque psoriasis: 16-week efficacy and safety results
    Papp, Kim A.
    Menter, Martin A.
    Abe, Masatoshi
    Elewski, Boni E.
    Feldman, Steven R.
    Gottlieb, Alice G.
    Thaci, Diamant
    Luger, Thomas
    Tatulych, Svitlana
    Gupta, Pankaj
    Proulx, James
    Lan, Shu-Ping
    Wolk, Robert
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB66 - AB66
  • [10] Bimekizumab in moderate-to-severe plaque psoriasis: population pharmacokinetic and pharmacodynamic relationships
    Vajjah, P.
    Acharya, C.
    Brekkan, A.
    Zamacona, M.
    Nemansky, M.
    Peterson, L.
    MacPherson, M.
    Oliver, R.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E47 - E48
12345